1 Min Read
Aug 21 (Reuters) - Amgen Inc
* Amgen to present new data from the Repatha cardiovascular outcomes study at ESC congress 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.